
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE53417B8AF3DA3305417B0006FE431B.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="medicines">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371971/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Medicines">
<meta name="citation_title" content="Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications">
<meta name="citation_author" content="Yeung-Ae Park">
<meta name="citation_author_institution" content="Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne 3050, Australia">
<meta name="citation_author_institution" content="Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne 3050, Australia">
<meta name="citation_author_institution" content="Department of Endocrinology and Diabetes, Eastern Health, Melbourne 3128, Australia">
<meta name="citation_author" content="Anya Kitt Lee">
<meta name="citation_author_institution" content="Monash School of Medicine, Monash University, Melbourne 3168, Australia">
<meta name="citation_author" content="Rahul D Barmanray">
<meta name="citation_author_institution" content="Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne 3050, Australia">
<meta name="citation_author_institution" content="Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne 3050, Australia">
<meta name="citation_author_institution" content="Department of Diabetes and Endocrinology, Western Health, Melbourne 3021, Australia">
<meta name="citation_author_institution" content="Australian Centre for Accelerating Diabetes Innovations (ACADI), University of Melbourne, Melbourne 3010, Australia">
<meta name="citation_author" content="Frank Gao">
<meta name="citation_author_institution" content="Australian Centre for Accelerating Diabetes Innovations (ACADI), University of Melbourne, Melbourne 3010, Australia">
<meta name="citation_author_institution" content="Department of Medicine, Austin Health, University of Melbourne, Melbourne 3084, Australia">
<meta name="citation_author_institution" content="Department of Endocrinology, Austin Health, Melbourne 3084, Australia">
<meta name="citation_author" content="Spiros Fourlanos">
<meta name="citation_author_institution" content="Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne 3050, Australia">
<meta name="citation_author_institution" content="Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne 3050, Australia">
<meta name="citation_author_institution" content="Australian Centre for Accelerating Diabetes Innovations (ACADI), University of Melbourne, Melbourne 3010, Australia">
<meta name="citation_author" content="Chris Gilfillan">
<meta name="citation_author_institution" content="Department of Endocrinology and Diabetes, Eastern Health, Melbourne 3128, Australia">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="12">
<meta name="citation_issue" content="3">
<meta name="citation_firstpage" content="21">
<meta name="citation_doi" content="10.3390/medicines12030021">
<meta name="citation_pmid" content="40843859">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371971/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371971/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371971/pdf/medicines-12-00021.pdf">
<meta name="description" content="Background/Objectives: Sodium–glucose co-transporter 2 inhibitors (SGLT2i) are associated with increased rates of diabetic ketoacidosis (DKA). The difference in the management and outcomes of SGLT2i-associated DKA (SGLT2i DKA) from ...">
<meta name="og:title" content="Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Background/Objectives: Sodium–glucose co-transporter 2 inhibitors (SGLT2i) are associated with increased rates of diabetic ketoacidosis (DKA). The difference in the management and outcomes of SGLT2i-associated DKA (SGLT2i DKA) from ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371971/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12371971">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/medicines12030021"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/medicines-12-00021.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371971%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12371971/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12371971/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371971/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-medicines.png" alt="Medicines logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Medicines" title="Link to Medicines" shape="default" href="http://www.mdpi.com/journal/medicines" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Medicines (Basel)</button></div>. 2025 Aug 19;12(3):21. doi: <a href="https://doi.org/10.3390/medicines12030021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/medicines12030021</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Medicines%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Medicines%20(Basel)%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Medicines%20(Basel)%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Medicines%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Park%20YA%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yeung-Ae Park</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yeung-Ae Park</span></h3>
<div class="p">
<sup>1</sup>Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne 3050, Australia</div>
<div class="p">
<sup>2</sup>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne 3050, Australia</div>
<div class="p">
<sup>3</sup>Department of Endocrinology and Diabetes, Eastern Health, Melbourne 3128, Australia</div>
<div>Conceptualization, Methodology, Formal analysis, Writing – original draft, Writing – review &amp; editing, Visualization</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Park%20YA%22%5BAuthor%5D" class="usa-link"><span class="name western">Yeung-Ae Park</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20AK%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Anya Kitt Lee</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Anya Kitt Lee</span></h3>
<div class="p">
<sup>4</sup>Monash School of Medicine, Monash University, Melbourne 3168, Australia</div>
<div>Formal analysis, Data curation, Writing – original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20AK%22%5BAuthor%5D" class="usa-link"><span class="name western">Anya Kitt Lee</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Barmanray%20RD%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Rahul D Barmanray</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Rahul D Barmanray</span></h3>
<div class="p">
<sup>1</sup>Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne 3050, Australia</div>
<div class="p">
<sup>2</sup>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne 3050, Australia</div>
<div class="p">
<sup>5</sup>Department of Diabetes and Endocrinology, Western Health, Melbourne 3021, Australia</div>
<div class="p">
<sup>6</sup>Australian Centre for Accelerating Diabetes Innovations (ACADI), University of Melbourne, Melbourne 3010, Australia</div>
<div>Methodology, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Barmanray%20RD%22%5BAuthor%5D" class="usa-link"><span class="name western">Rahul D Barmanray</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>5,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gao%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Frank Gao</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Frank Gao</span></h3>
<div class="p">
<sup>6</sup>Australian Centre for Accelerating Diabetes Innovations (ACADI), University of Melbourne, Melbourne 3010, Australia</div>
<div class="p">
<sup>7</sup>Department of Medicine, Austin Health, University of Melbourne, Melbourne 3084, Australia</div>
<div class="p">
<sup>8</sup>Department of Endocrinology, Austin Health, Melbourne 3084, Australia</div>
<div>Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gao%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Frank Gao</span></a>
</div>
</div>
<sup>6,</sup><sup>7,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fourlanos%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Spiros Fourlanos</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Spiros Fourlanos</span></h3>
<div class="p">
<sup>1</sup>Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne 3050, Australia</div>
<div class="p">
<sup>2</sup>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne 3050, Australia</div>
<div class="p">
<sup>6</sup>Australian Centre for Accelerating Diabetes Innovations (ACADI), University of Melbourne, Melbourne 3010, Australia</div>
<div>Methodology, Writing – review &amp; editing, Supervision</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fourlanos%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Spiros Fourlanos</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>6,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gilfillan%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Chris Gilfillan</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Chris Gilfillan</span></h3>
<div class="p">
<sup>3</sup>Department of Endocrinology and Diabetes, Eastern Health, Melbourne 3128, Australia</div>
<div>Conceptualization, Methodology, Writing – review &amp; editing, Supervision</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gilfillan%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chris Gilfillan</span></a>
</div>
</div>
<sup>3,</sup><sup>†</sup>
</div>
<div class="cg p">Editor: <span class="name western">M Rosa Bernal-López</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-medicines-12-00021">
<sup>1</sup>Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne 3050, Australia</div>
<div id="af2-medicines-12-00021">
<sup>2</sup>Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne 3050, Australia</div>
<div id="af3-medicines-12-00021">
<sup>3</sup>Department of Endocrinology and Diabetes, Eastern Health, Melbourne 3128, Australia</div>
<div id="af4-medicines-12-00021">
<sup>4</sup>Monash School of Medicine, Monash University, Melbourne 3168, Australia</div>
<div id="af5-medicines-12-00021">
<sup>5</sup>Department of Diabetes and Endocrinology, Western Health, Melbourne 3021, Australia</div>
<div id="af6-medicines-12-00021">
<sup>6</sup>Australian Centre for Accelerating Diabetes Innovations (ACADI), University of Melbourne, Melbourne 3010, Australia</div>
<div id="af7-medicines-12-00021">
<sup>7</sup>Department of Medicine, Austin Health, University of Melbourne, Melbourne 3084, Australia</div>
<div id="af8-medicines-12-00021">
<sup>8</sup>Department of Endocrinology, Austin Health, Melbourne 3084, Australia</div>
<div class="author-notes p">
<div class="fn" id="c1-medicines-12-00021">
<sup>*</sup><p class="display-inline">Correspondence: <span>yeungae.park@mh.org.au</span></p>
</div>
<div class="fn" id="fn1-medicines-12-00021">
<sup>†</sup><p class="display-inline">Joint senior authorship.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Yeung-Ae Park</span></strong>: <span class="role">Conceptualization, Methodology, Formal analysis, Writing – original draft, Writing – review &amp; editing, Visualization</span>
</div>
<div>
<strong class="contrib"><span class="name western">Anya Kitt Lee</span></strong>: <span class="role">Formal analysis, Data curation, Writing – original draft</span>
</div>
<div>
<strong class="contrib"><span class="name western">Rahul D Barmanray</span></strong>: <span class="role">Methodology, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Frank Gao</span></strong>: <span class="role">Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Spiros Fourlanos</span></strong>: <span class="role">Methodology, Writing – review &amp; editing, Supervision</span>
</div>
<div>
<strong class="contrib"><span class="name western">Chris Gilfillan</span></strong>: <span class="role">Conceptualization, Methodology, Writing – review &amp; editing, Supervision</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">M Rosa Bernal-López</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jun 10; Revised 2025 Jul 9; Accepted 2025 Aug 13; Collection date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12371971  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40843859/" class="usa-link">40843859</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Background/Objectives: Sodium–glucose co-transporter 2 inhibitors (SGLT2i) are associated with increased rates of diabetic ketoacidosis (DKA). The difference in the management and outcomes of SGLT2i-associated DKA (SGLT2i DKA) from non-SGLT2i-associated DKA (non-SGLT2i DKA) remains unclear due to a lack of specific reporting on dextrose and insulin. This study aims to compare the management and outcome of SGLT2i and non-SGLT2i diabetic ketoacidosis. Methods: In this retrospective cohort study, patients admitted to the Intensive Care Unit (ICU) for diabetic ketosis between 1 January 2020 to 31 December 2021 at a tertiary hospital were identified. For each SGLT2i diabetic ketosis, two non-SGLT2i diabetic ketosis admissions closest to the SGLT2i admission date were evaluated for comparison. Clinical data including biochemistry, ICU length of stay (LOS), time to normalize acidemia and ketonemia, dextrose and insulin requirements, were evaluated. Results: In the SGLT2i group (<em>n</em> = 30), there were 22 DKA and 8 diabetic ketosis cases; in the non-SGLT2i group (<em>n</em> = 60), there were 54 DKA and 6 diabetic ketosis cases. SGLT2i DKA (<em>n</em> = 22) required 62% greater total insulin (154 [117–249] vs. 95 [59–150] units; <em>p</em> = 0.004), which remained statistically significant after weight adjustment (<em>p</em> = 0.02), and longer ICU LOS (52 [42–97] vs. 39 [23–68] hours; <em>p</em> = 0.01) compared to non-SGLT2i DKA (<em>n</em> = 54), despite a comparable time to DKA resolution (22 [15–35] vs. 20 [15–35] hours; <em>p</em> = 0.91). In the intercurrent illness subgroup analysis, neither total insulin dose nor ICU LOS remained statistically significantly different between SGLT2i (<em>n</em> = 16) and non-SGLT2i DKA (<em>n</em> = 21). The majority of cases received 10% dextrose and variable rate intravenous insulin infusion (VRIII). Conclusions: The greater insulin requirement in SGLT2i DKA compared to non-SGLT2i DKA may be explained by the greater proportion of precipitating intercurrent illnesses and demographic differences in SGLT2i DKA, highlighting that SGLT2i DKA (predominantly comprising T2D) and non-SGLT2i DKA (predominantly comprising T1D) represent distinct clinical entities. Our findings in comparison to the literature imply that in SGLT2i DKA, the need for prolonged IV insulin infusion may be reduced through intensive management using intravenous 10% dextrose and VRIII. Prospective studies are warranted to evaluate the efficacy of different management strategies for SGLT2i DKA.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> diabetes, diabetic ketoacidosis, insulin resistance, sodium–glucose co-transporter 2 inhibitors, treatment outcome</p></section></section><section id="sec1-medicines-12-00021"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Sodium–glucose co-transporter 2 inhibitors (SGLT2i) have emerged as highly effective therapies for type 2 diabetes (T2D) given their glycemic efficacy, effects on weight loss and well-recognized cardio- and reno-protective benefits [<a href="#B1-medicines-12-00021" class="usa-link" aria-describedby="B1-medicines-12-00021">1</a>]. Key consensus international guidelines recommend SGLT2i use in people with T2D who have established cardiovascular or kidney disease or multiple risk factors for cardiovascular disease [<a href="#B2-medicines-12-00021" class="usa-link" aria-describedby="B2-medicines-12-00021">2</a>,<a href="#B3-medicines-12-00021" class="usa-link" aria-describedby="B3-medicines-12-00021">3</a>].</p>
<p>In 2015, the United States Food and Drug Administration warned that SGLT2i use is associated with diabetic ketoacidosis (DKA) [<a href="#B4-medicines-12-00021" class="usa-link" aria-describedby="B4-medicines-12-00021">4</a>]. The use of SGLT2i in patients with T2D has been associated with an increased risk of developing DKA by approximately two-fold compared to non-SGLT2i users [<a href="#B5-medicines-12-00021" class="usa-link" aria-describedby="B5-medicines-12-00021">5</a>,<a href="#B6-medicines-12-00021" class="usa-link" aria-describedby="B6-medicines-12-00021">6</a>], with an incidence rate of 1.02/1000 for SGLT2i users and 0.69/1000 for SGLT2i non-users [<a href="#B7-medicines-12-00021" class="usa-link" aria-describedby="B7-medicines-12-00021">7</a>]. SGLT2i initiation in hospital has similarly been associated with numerically higher ketoacidosis rates (0.210 per 100 person-years) compared with control (0.140 per 100 person-years) [<a href="#B8-medicines-12-00021" class="usa-link" aria-describedby="B8-medicines-12-00021">8</a>]. Traditionally, DKA presents with hyperglycemia and ketoacidosis; however, with SGLT2i use, patients may present with euglycemic DKA [<a href="#B9-medicines-12-00021" class="usa-link" aria-describedby="B9-medicines-12-00021">9</a>].</p>
<p>Although the increased incidence, demographic and initial biochemical differences between SGLT2i DKA and non-SGLT2i DKA have been described, there is a paucity of studies evaluating the management practices and comparison of outcomes between SGLT2i DKA and non-SGLT2i DKA. The duration of SGLT2i DKA has been previously described to be significantly greater compared to non-SGLT2i DKA [<a href="#B10-medicines-12-00021" class="usa-link" aria-describedby="B10-medicines-12-00021">10</a>,<a href="#B11-medicines-12-00021" class="usa-link" aria-describedby="B11-medicines-12-00021">11</a>] or all-cause DKA [<a href="#B12-medicines-12-00021" class="usa-link" aria-describedby="B12-medicines-12-00021">12</a>]. Similarly, SGLT2i DKA has been associated with longer intensive care unit (ICU) length of stay (LOS) compared with non-SGLT2i DKA [<a href="#B10-medicines-12-00021" class="usa-link" aria-describedby="B10-medicines-12-00021">10</a>,<a href="#B13-medicines-12-00021" class="usa-link" aria-describedby="B13-medicines-12-00021">13</a>,<a href="#B14-medicines-12-00021" class="usa-link" aria-describedby="B14-medicines-12-00021">14</a>]. However, a lack of reported data on intravenous (IV) dextrose concentrations and insulin regimens has limited the assessment of optimal fluid and insulin management practices for SGLT2i DKA.</p>
<p>We aimed to compare the management and outcomes of SGLT2i DKA and ketosis with non-SGLT2i DKA and ketosis, including the amount of insulin required, IV fluid management with dextrose specifications, time to DKA resolution, and ICU LOS.</p></section><section id="sec2-medicines-12-00021"><h2 class="pmc_sec_title">2. Material and Methods</h2>
<p>This retrospective cohort study of patients admitted to the ICU for diabetic ketosis over two years between 1 January 2020 and 31 December 2021 at a tertiary hospital network was approved by the Office of Research and Ethics at Eastern Health. All patients admitted to the ICU with SGLT2i diabetic ketosis were included in the study. The patients were identified through International Classification of Diseases codes for DKA. Individuals with SGLT2i DKA (beta-hydroxybutyrate [BOHB] ketones &gt; 0.6 mmol/L; pH &lt; 7.30) or SGLT2i diabetic ketosis (BOHB ketones &gt; 0.6 mmol/L; pH ≥ 7.30) were included in the SGLT2i group. Patients without confirmed ketonemia were excluded. SGLT2i usage was determined based on documentation as a current medication in the admission medical records and through pharmacy medication reconciliation. For each case of SGLT2i DKA or SGLT2i diabetic ketosis, two non-SGLT2i DKA or diabetic ketosis admissions that occurred closest to the index SGLT2i-associated admission date were evaluated for comparison. Where cases of SGLT2i DKA or SGLT2i diabetic ketosis occurred on consecutive or identical admission dates, the next closest non-SGLT2i DKA or diabetic ketosis admissions to the index SGLT2i admission dates were compared. There were no exclusion criteria. Clinical and laboratory information, including patient demographics and diabetes-related clinical history, were collected from the medical record. Precipitating intercurrent illnesses were defined as infection, acute myocardial infarction, pancreatitis, surgery, and steroid use.</p>
<p>The main outcome measures were total insulin requirement during diabetic ketosis or DKA treatment, time taken to normalize acidemia (pH 7.35–7.45) and ketonemia (BOHB ketone &lt; 0.3 mmol/L), and ICU LOS. Other outcomes included IV fluids use, including type, infusion rates, and the total amount used. Recurrence of ketonemia was defined as BOHB ketones &gt; 1.0 mmol/L after falling to &lt;0.3 mmol/L.</p>
<p>An identical protocol was utilized for SGLT2i and non-SGLT2i DKA. Per protocol, if blood glucose level (BGL) was &lt;15 mmol/L, 10% dextrose was commenced at 83 mL/h, and the insulin infusion rate was titrated according to the blood glucose level.</p>
<p>Statistical analysis was conducted using IBM SPSS statistics for Windows, Version 24.0 (Armonk, NY, USA: IBM Corp.). Variables were checked for distribution and normality prior to analysis. Continuous variables are presented as mean  ±  standard deviation or medians (interquartile range [IQR]). Fisher’s exact tests and binary logistic regression were utilized for categorical variables. Parametric and non-parametric tests were utilized to assess the associations between continuous variables. All statistical tests were 2-tailed, and statistical significance was set at <em>p</em> &lt; 0.05.</p></section><section id="sec3-medicines-12-00021"><h2 class="pmc_sec_title">3. Results</h2>
<section id="sec3dot1-medicines-12-00021"><h3 class="pmc_sec_title">3.1. Baseline Demographics of the Study Population</h3>
<p>Twenty-two cases of SGLT2i DKA and eight cases of SGLT2i diabetic ketosis were identified in the SGLT2i group (<em>n</em> = 30). For comparison, 54 cases of non-SGLT2i DKA and six cases of non-SGLT2i diabetic ketosis were analyzed in the non-SGLT2i group (<em>n</em> = 60). The SGLT2i group consisted of older people (53.0 [47.0–62.3] vs. 31.0 [24.3–48.0] years; <em>p</em> &lt; 0.001) with higher body mass indexes (BMI) (31.1 [26.5–35.6] vs. 24.2 [21.7–27.2] kg/m<sup>2</sup>; <em>p</em> &lt; 0.001) than the non-SGLT2i group. The SGLT2i group consisted largely of people with T2D (83%), whereas the non-SGLT2i group only consisted of people with type 1 diabetes (T1D) (100%). Three patients with SGLT2i (10%) had a diagnosis revised from T2D to latent autoimmune diabetes in adults (LADA) due to diabetes-related autoantibody positivity during admission.</p></section><section id="sec3dot2-medicines-12-00021"><h3 class="pmc_sec_title">3.2. Initial Biochemistry and Presentations</h3>
<p>The SGLT2i group had significantly lower glucose (14.1 [9.9–26.5] vs. 27.1 [23.9–36.6] mmol/L; <em>p</em> &lt; 0.001) and ketone levels (4.1 [3.6–5.5] vs. 6.2 [4.5–7.0] mmol/L; <em>p</em> &lt; 0.001), and higher serum bicarbonate levels (14.0 [11.0–19.0] vs. 9.5 [6.0–13.0] mmol/L; <em>p</em> = 0.003) on initial presentation compared to the non-SGLT2i group (<a href="#medicines-12-00021-t001" class="usa-link">Table 1</a>). Precipitating intercurrent illnesses were more prevalent in the SGLT2i group than in the non-SGLT2i group (73% vs. 42%; <em>p</em> = 0.007). The most common precipitant for the SGLT2i group was infection (60%), whilst insulin omission (53%) was the most common precipitant of the non-SGLT2i group, followed by infection (37%).</p>
<section class="tw xbox font-sm" id="medicines-12-00021-t001"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Comparison of baseline characteristics and initial biochemistry between SGLT2i and non-SGLT2i groups.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SGLT2i Group<br>(<em>n</em> = 30)</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Non-SGLT2i Group<br>(<em>n</em> = 60)</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<em>p</em>-Value</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Gender (%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.26</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Male</td>
<td align="center" valign="middle" rowspan="1" colspan="1">19 (63)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">29 (48)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Female</td>
<td align="center" valign="middle" rowspan="1" colspan="1">11 (37)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">31 (52) </td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Age (years) †</td>
<td align="center" valign="middle" rowspan="1" colspan="1">53.0 (47.0−62.3)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">31.0 (24.3−48.0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>) †</td>
<td align="center" valign="middle" rowspan="1" colspan="1">31.1 (26.5−35.6)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">24.2 (21.7−27.2)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Duration of diabetes (years) †</td>
<td align="center" valign="middle" rowspan="1" colspan="1">6.0 (2.8−16.8)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">9.0 (0.0−18.0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.80</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Types of diabetes (%) ‡</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Type 1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1 (3)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">60 (100)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Type 2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">25 (83)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">LADA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4 (13)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Premorbid antihyperglycemic agents (%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.001</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Insulin therapy</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12 (40)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">45 (75)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Non-insulin therapy</td>
<td align="center" valign="middle" rowspan="1" colspan="1">18 (60) </td>
<td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">None</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">15 (25)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">HbA1c *</td>
<td align="center" valign="middle" rowspan="1" colspan="1">9.8 ± 3.0 % <br>(84 ± 9 mmol/mol)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">9.7 ± 2.5 % <br>(83 ± 4 mmol/mol)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.74</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Diabetes complications (%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Ischemic heart disease</td>
<td align="center" valign="middle" rowspan="1" colspan="1">6 (20)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4 (7)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.07</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Stroke</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3 (10)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">5 (8)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.54</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Peripheral vascular disease</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2 (7)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4 (7)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.68</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Peripheral neuropathy</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2 (7)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">9 (15)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.22</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Retinopathy</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3 (10)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">8 (13)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.47</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Chronic kidney disease</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Initial DKA biochemistry</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">BGL (mmol/L) †</td>
<td align="center" valign="middle" rowspan="1" colspan="1">14.1 (9.9−26.5)</td>
<td align="center" valign="middle" rowspan="1" colspan="1"> 27.1 (23.9−36.6)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">BOHB Ketones (mmol/L) †</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4.1 (3.6−5.5) </td>
<td align="center" valign="middle" rowspan="1" colspan="1">6.2 (4.5−7.0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">pH †</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7.22 (6.98−7.34)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7.10 (6.95−7.21)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.07</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Serum bicarbonate (mmol/L) †</td>
<td align="center" valign="middle" rowspan="1" colspan="1">14.0 (11.0−19.0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">9.5 (6.0−13.0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.003</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Precipitants of DKA (%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Infection</td>
<td align="center" valign="middle" rowspan="1" colspan="1">18 (60)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">22 (37)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.04</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Missed insulin</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4 (13)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">32 (53) </td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.001</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Decreased oral intake</td>
<td align="center" valign="middle" rowspan="1" colspan="1">8 (27)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">6 (10) </td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.06</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">New onset diabetes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">13 (22)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.004</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Alcohol</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2 (7) </td>
<td align="center" valign="middle" rowspan="1" colspan="1">9 (15)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.32</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Acute myocardial infarct</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3 (10)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1 (2) </td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.11</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Steroid therapy</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4 (13)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0 (0) </td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Pancreatitis</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2 (3) </td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.55</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Surgery</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2 (7)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0 (0) </td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.11</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ketogenic diet</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (7) </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.11</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/medicines-12-00021-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn3"><p>*, expressed as mean ± standard deviation; †, expressed as median (25th percentile–75th percentile); ‡, after revision of diabetes type; BGL, blood glucose level; BMI, body mass index; BOHB, Beta-hydroxybutyrate; DKA, diabetic ketoacidosis; HbA1C, hemoglobin A1C; LADA, latent autoimmune diabetes in adults; SGLT2i, sodium–glucose co-transporter 2 inhibitors.</p></div></div></section></section><section id="sec3dot3-medicines-12-00021"><h3 class="pmc_sec_title">3.3. Management and Outcomes of DKA</h3>
<p>The SGLT2i group (<em>n</em> = 30) required significantly greater IV insulin (150 [107–228] vs. 89 [55–147] units; <em>p</em> = 0.004) and had longer ICU LOS (56 [43–101] vs. 40 [23–67] hours; <em>p</em> = 0.002) than the non-SGLT2i group (<em>n</em> = 60) despite comparable time to ketonemia and acidemia resolution (<a href="#medicines-12-00021-t002" class="usa-link">Table 2</a>). SGLT2i DKA (<em>n</em> = 22) required 62% greater total insulin (154 [117–249] vs. 95 [59–150] units; <em>p</em> = 0.004), which remained statistically significant after adjustment for weight (1.87 [1.45–2.38] vs. 1.30 [0.75–1.96] units/kg; <em>p</em> = 0.02), and longer ICU LOS (52 [42–97] vs. 39 [23–68] hours; <em>p</em> = 0.01) compared to non-SGLT2i DKA (<em>n</em> = 54) (<a href="#medicines-12-00021-f001" class="usa-link">Figure 1</a>), despite a comparable time to DKA resolution (22 [15–35] vs. 20 [15–35] hours; <em>p</em> = 0.91). In one case of SGLT2i DKA and four cases of SGLT2i diabetic ketosis, subcutaneous insulin was utilized without IV insulin. There was no statistically significant difference in the initial BOHB ketone levels between the individuals managed with IV vs. subcutaneous insulin (5.9 [4.0–6.8] vs. 3.9 [3.5–4.0] mmol/L; <em>p</em> = 0.08). Compared to the subcutaneous insulin subset of SGLT2i group (<em>n</em> = 5), IV insulin subset of the SGLT2i group (<em>n</em> = 25) required a greater amount of insulin (151 [107–253] vs. 36 [31–61] units; <em>p</em> = 0.001), which remained statistically significant after adjustment for weight (1.80 [1.11–2.38] vs. 0.58 [0.34–0.80] units/kg; <em>p</em> = 0.01), to achieve comparable resolution of ketonemia (19 [15–33] vs. 32 [14–46] hours; <em>p</em> = 0.45). Variable rate intravenous insulin infusion (VRIII) was utilized in all patients managed with IV insulin as per protocol.</p>
<section class="tw xbox font-sm" id="medicines-12-00021-t002"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Comparison of management and outcomes between SGLT2i and non-SGLT2i groups.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SGLT2i Group<br>(<em>n</em> = 30)</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Non-SGLT2i Group<br>(<em>n</em> = 60)</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<em>p</em>-Value</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Outcomes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">ICU LOS (hours) *</td>
<td align="center" valign="middle" rowspan="1" colspan="1">56 (43–101)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">40 (23–67)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.002</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Time to pH resolution (hours) *</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7 (1–14)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">10 (6–13)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.21</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Time to ketonemia resolution (hours) *</td>
<td align="center" valign="middle" rowspan="1" colspan="1">22 (15–36)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">20 (14–31)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.91</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Recurrent ketonemia (%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">8 (27)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">17 (28)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.00</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Mortality (%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3 (10)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.04</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Insulin administration</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Total insulin dose (units) *</td>
<td align="center" valign="middle" rowspan="1" colspan="1">136 (64–217)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">89 (55–147)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.06</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Total IV insulin dose (units) *</td>
<td align="center" valign="middle" rowspan="1" colspan="1">150 (107–228) <sup>†</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">89 (55–147)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.004</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Total IV insulin duration (hours) *</td>
<td align="center" valign="middle" rowspan="1" colspan="1">35 (26–51) <sup>†</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">26 (17–44)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.08</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Total IV insulin over 24 h (units) *</td>
<td align="center" valign="middle" rowspan="1" colspan="1">93 (71–137) <sup>†</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">81 (54–111)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.04</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Average IV insulin infusion rate (unit/h) *</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3.9 (3.0–5.7) <sup>†</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3.4 (2.3–4.6)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.04</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">IV fluids administration</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">5% dextrose (%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">9 (30)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">8 (14)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.09</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Amount (liters) ‡</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.4 ± 0.9</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.2 ± 0.6</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.03</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Rate (mL/h) *</td>
<td align="center" valign="middle" rowspan="1" colspan="1">83 (83–100)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">125 (83–146)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.24</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">10% dextrose (%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">25 (83)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">56 (93)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.11</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Amount (liters) ‡</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.4 ± 1.1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.9 ± 1.4</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.25</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Rate (mL/h) ‡</td>
<td align="center" valign="middle" rowspan="1" colspan="1">85 ± 6 </td>
<td align="center" valign="middle" rowspan="1" colspan="1">82 ± 24</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.57</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Total dextrose (g) ‡</td>
<td align="center" valign="middle" rowspan="1" colspan="1">157 ± 117</td>
<td align="center" valign="middle" rowspan="1" colspan="1">195 ± 135</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.19</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">NaCl 0.9% (%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">24 (80)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">56 (93)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.08</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Amount (liters) *</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2.4 (1.2–3.8)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3.0 (2.0–4.5)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.24</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">CSL (%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">8 (27)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">26 (43)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.17</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Amount (liters) ‡</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.8 ± 1.9</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.9 ± 1.2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.61</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Total amount of IV fluids ‡</td>
<td align="center" valign="middle" rowspan="1" colspan="1">5.0 ± 3.2 </td>
<td align="center" valign="middle" rowspan="1" colspan="1">6.3 ± 2.8</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.06</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Complications (%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Hypokalemia</td>
<td align="center" valign="middle" rowspan="1" colspan="1">20 (67)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">37 (62) </td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.82</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Hypoglycemia</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4 (13)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">14 (23)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.52</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vascular complications (e.g., thrombophlebitis)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.00</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/medicines-12-00021-t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn4"><p>*, expressed as median (25th percentile–75th percentile); <sup>†</sup>, in 25 patients who received IV insulin; ‡, expressed as mean ± standard deviation; BGL, blood glucose level; CSL, compound sodium lactate; DKA, diabetic ketoacidosis; ICU, intensive care unit; IV, intravenous; LOS, length of stay; NaCl, sodium chloride; SGLT2i, sodium–glucose co-transporter 2 inhibitors.</p></div></div></section><figure class="fig xbox font-sm" id="medicines-12-00021-f001"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371971_medicines-12-00021-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac2e/12371971/58f1d666cc12/medicines-12-00021-g001.jpg" loading="lazy" height="982" width="746" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/medicines-12-00021-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Comparison of (<strong>A</strong>) total insulin dose required for DKA resolution and (<strong>B</strong>) ICU LOS between SGLT2i DKA and non-SGLT2i DKA in the total DKA cohort and the subgroup with intercurrent illnesses. *, <em>p</em> &lt; 0.05; **, <em>p</em> &lt; 0.01; ns, not significant; DKA, diabetic ketoacidosis; ICU, intensive care unit; LOS, length of stay; SGLT2i, sodium–glucose co-transporter 2 inhibitors.</p></figcaption></figure><p>There was no significant difference in the time taken for normalization of pH (11 [6–16] vs. 10 [6–14] hours; <em>p</em> = 0.94) and BOHB ketones (22 [15–35] vs. 20 [15–32] hours; <em>p</em> = 0.91) between SGLT2i (<em>n</em> = 22) and non-SGLT2i DKA (<em>n</em> = 54). In the subgroup analysis of precipitating intercurrent illnesses in SGLT2i (<em>n</em> = 16) and non-SGLT2i DKA (<em>n</em> = 21), neither total insulin dose (162 [117–247] vs. 125 [71–249] units; <em>p</em> = 0.17) nor ICU LOS (52 [36–108] vs. 45 [26–86] hours; <em>p</em> = 0.33) remained statistically significant (<a href="#medicines-12-00021-f001" class="usa-link">Figure 1</a>). In the subset analysis by four groups of non-SGLT2i DKA without intercurrent illness (<em>n</em> = 33), non-SGLT2i DKA with intercurrent illness (<em>n</em> = 21), SGLT2i DKA without intercurrent illness (<em>n</em> = 6) and SGLT2i DKA with intercurrent illness (<em>n</em> = 16), the total insulin dose and ICU LOS were significantly different between the groups (70 [56–137] vs. 125 [71–249] vs. 141 [112–229] vs. 157 [133–231] units; <em>p</em> = 0.01) and (34 [21–56] vs. 45 [26–86] vs. 54 [48–74] vs. 52 [36–108] hours; <em>p</em> = 0.02), respectively. In those without intercurrent illnesses, the total insulin dose (<em>p</em> = 0.03) and ICU LOS (<em>p</em> = 0.02) were significantly greater in SGLT2i DKA compared to non-SGLT2i DKA. In those with intercurrent illnesses, the total insulin dose (<em>p</em> = 0.18) and ICU LOS (<em>p</em> = 0.34) were no longer statistically significantly different between SGLT2i DKA and non-SGLT2i DKA. In non-SGLT2i DKA, there was a trend toward greater total insulin dose (<em>p</em> = 0.09) and ICU LOS (<em>p</em> = 0.07) in those with intercurrent illnesses compared to those without. In SGLT2i DKA, the total insulin dose (<em>p</em> = 0.69) and ICU LOS (<em>p</em> = 1.00) were similar between those with intercurrent illnesses and those without.</p>
<p>The most common dextrose concentration used was 10% dextrose, used in 83% in the SGLT2i group and 93% in the non-SGLT2i group. The two groups had no difference in the total dextrose amount or total IV fluid volume administered (<a href="#medicines-12-00021-t002" class="usa-link">Table 2</a>). Higher mortality was observed with the SGLT2i group compared to the non-SGLT2i group (<em>n</em> = 3 [10%] vs. <em>n</em> = 0 [0%]; <em>p</em> = 0.04) in the setting of concurrent illnesses (bowel ischemia, metastatic breast cancer and stroke).</p></section><section id="sec3dot4-medicines-12-00021"><h3 class="pmc_sec_title">3.4. Complications of DKA Management</h3>
<p>Hypoglycemia occurred less frequently in the SGLT2i group compared to the non-SGLT2i group but was not significantly different (13% vs. 23%; <em>p</em> = 0.521). There were no vascular complications, such as thrombophlebitis, even in those managed with 10% dextrose. Hypokalemia was common in both groups, but no arrhythmias related to hypokalemia occurred.</p></section><section id="sec3dot5-medicines-12-00021"><h3 class="pmc_sec_title">3.5. Management Post DKA Resolution</h3>
<p>Recurrent ketonemia occurred in over one-quarter of cases and was similar in both groups (<a href="#medicines-12-00021-t002" class="usa-link">Table 2</a>). The recurrence of ketonemia was not correlated with ICU LOS (<em>p</em> = 0.58), diabetes duration (<em>p</em> = 0.34), initial biochemistry (glucose [<em>p</em> = 0.59], ketones [<em>p</em> = 0.97], pH [<em>p</em> = 0.74], bicarbonate [<em>p</em> = 0.17]), time to ketonemia resolution (<em>p</em> = 0.22), time to acidemia resolution (<em>p</em> = 0.27), total insulin dose (<em>p</em> = 0.95), c-peptide (<em>p</em> = 0.94), hemoglobin A1C (<em>p</em> = 0.57), or premorbid total daily insulin dose (<em>p</em> = 0.85). Greater total dextrose (233 [151–329] vs. 128 [75–221] g; <em>p</em> = 0.008) and IV fluid volume (7.5 [5.0–9.5] vs. 5.3 [3.0–6.7] L; <em>p</em> = 0.002) were observed in individuals with recurrent ketonemia compared to those without, reflective of the IV dextrose treatment following the recurrence of ketonemia. In the SGLT2i group, 21 (70%) were discharged with subcutaneous insulin, with 12 of them being new to insulin therapy. SGLT2i was ceased in all SGLT2i DKA and SGLT2i diabetic ketosis; however, consideration of recommencement was advised in those with identified and preventable precipitants and the ability to comprehend and follow SGLT2i action plans.</p></section></section><section id="sec4-medicines-12-00021"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>Our results demonstrate for the first time that the greater prevalence of intercurrent illnesses is a potential explanation for the higher insulin requirement and longer ICU LOS observed in SGLT2i DKA compared to non-SGLT2i DKA. Inflammation is an important factor in the pathogenesis of insulin resistance in T2D [<a href="#B15-medicines-12-00021" class="usa-link" aria-describedby="B15-medicines-12-00021">15</a>], via pro-inflammatory cytokines in adipose tissue, skeletal muscle and liver [<a href="#B16-medicines-12-00021" class="usa-link" aria-describedby="B16-medicines-12-00021">16</a>]. Similarly, during infection and sepsis, insulin resistance is promoted in hepatocytes via interleukin (IL)-1beta, tumor necrosis factor and IL-6 and gluconeogenesis in the liver [<a href="#B17-medicines-12-00021" class="usa-link" aria-describedby="B17-medicines-12-00021">17</a>] via a systemic neuroendocrine response, including the release of cortisol, norepinephrine and epinephrine [<a href="#B18-medicines-12-00021" class="usa-link" aria-describedby="B18-medicines-12-00021">18</a>]. These processes theoretically affect all individuals with diabetes regardless of their underlying diabetes type. In other situations of physiological stress, such as myocardial infarction, acute insulin resistance has been demonstrated even in patients without diabetes [<a href="#B19-medicines-12-00021" class="usa-link" aria-describedby="B19-medicines-12-00021">19</a>]. The loss of statistical significance in total insulin dose between the SGLT2i and non-SGLT2i DKA cohorts with intercurrent illnesses, compared to the overall respective cohorts, was primarily driven by the increase in insulin requirements in the non-SGLT2i group with intercurrent illnesses. Our results suggest that even in younger and lean individuals with T1D, the effect of intercurrent illnesses such as infection and inflammation in insulin resistance is profound, thus requiring similar insulin requirement and ICU LOS as those with SGLT2i DKA, which typically represent the comorbid individuals with T2D and baseline insulin resistance precipitated by intercurrent illnesses. In contrast, the SGLT2i group showed only a minimal increase in insulin requirement in the setting of intercurrent illness, likely due to their baseline insulin-resistant state.</p>
<p>The lower initial glycaemia of the SGLT2i group compared to the non-SGLT2i group is well known and attributed to the glycorusic effects of SGLT2i [<a href="#B20-medicines-12-00021" class="usa-link" aria-describedby="B20-medicines-12-00021">20</a>]. The higher initial serum bicarbonate level of the SGLT2i group compared to the non-SGLT2i group in our cohort has been similarly observed by Umapathysivam et al., although statistical significance was not met [<a href="#B11-medicines-12-00021" class="usa-link" aria-describedby="B11-medicines-12-00021">11</a>]. Despite presenting with less severe initial hyperglycemia, ketonemia and acidemia, the SGLT2i group required a significantly greater amount of insulin to achieve a comparable resolution time of acidemia and ketonemia compared to the non-SGLT2i group. The explanation for this observation is likely multifactorial: (i) a higher proportion of intercurrent illness in SGLT2i DKA, (ii) demographic differences with the SGLT2i group consisting of largely patients with T2D with baseline insulin resistance than the non-SGLT2i group, (iii) delayed drug clearance with the half-life of SGLT2i being approximately 12 h, and (iv) pancreatic alpha cell secretion of glucagon and consequent hyperglucagonemia from SGLT2i [<a href="#B21-medicines-12-00021" class="usa-link" aria-describedby="B21-medicines-12-00021">21</a>], requiring treatment with greater insulin for ketone clearance compared to non-SGLT2i DKA. The differences observed between these cohorts reflect underlying demographic variations, highlighting that patients typically affected by SGLT2i DKA (primarily those with T2D) and non-SGLT2i DKA (primarily those with T1D) represent fundamentally different populations, rather than being solely attributable to the use of SGLT2i medication. The SGLT2i cohort included three patients whose diagnoses were revised from T2D to LADA, demonstrating that SGLT2i DKA may serve as an opportunity to reassess and refine the underlying diabetes diagnosis.</p>
<p>Greater ICU LOS was observed in SGLT2i DKA compared to non-SGLT2i DKA, with the difference disappearing when only comparing those with intercurrent illnesses. Similarly to our findings on insulin requirement, whilst ICU LOS numerically increased in non-SGLT2i DKA with intercurrent illnesses compared to those without, ICU LOS remained similar in SGLT2i DKA with intercurrent illnesses compared to those without. This suggests that the significant difference observed in ICU LOS between the overall cohorts of SGLT2i and non-SGLT2i DKA is primarily due to the differential prevalence of intercurrent illnesses. Our findings of greater ICU LOS in SGLT2i DKA align with several studies [<a href="#B10-medicines-12-00021" class="usa-link" aria-describedby="B10-medicines-12-00021">10</a>,<a href="#B13-medicines-12-00021" class="usa-link" aria-describedby="B13-medicines-12-00021">13</a>,<a href="#B14-medicines-12-00021" class="usa-link" aria-describedby="B14-medicines-12-00021">14</a>]; however, conflicting data exist [<a href="#B7-medicines-12-00021" class="usa-link" aria-describedby="B7-medicines-12-00021">7</a>]. Hamblin et al. [<a href="#B7-medicines-12-00021" class="usa-link" aria-describedby="B7-medicines-12-00021">7</a>] did not find longer ICU LOS in SGLT2i DKA, however the comparator group was non-SGLT2i DKA in T2D, which better resembles the demographic characteristics of the SGLT2i DKA group than the non-SGLT2i DKA in T1D, and the ICU LOS was calculated in days rather than hours, reducing the ability to detect small differences. Overall, the greater LOS and mortality in SGLT2i DKA in our study may reflect the underlying severity of intercurrent illnesses and the demographic differences between these cohorts rather than the DKA itself, given the comparable time to DKA resolution.</p>
<p>In contrast to previous studies describing the longer duration of SGLT2i DKA compared to non-SGLT2i DKA [<a href="#B10-medicines-12-00021" class="usa-link" aria-describedby="B10-medicines-12-00021">10</a>,<a href="#B11-medicines-12-00021" class="usa-link" aria-describedby="B11-medicines-12-00021">11</a>] or all-cause DKA [<a href="#B12-medicines-12-00021" class="usa-link" aria-describedby="B12-medicines-12-00021">12</a>], our study demonstrated no significant difference in time to ketonemia or acidemia resolution between the SGLT2i and non-SGLT2i groups. We postulate that this is due to the intensive insulin treatment enabled by a higher concentration of 10% dextrose. Improvement of intractable metabolic acidosis in SGLT2i DKA has been demonstrated after switching from 5% dextrose to high-calorie glucose infusion, such as 10% dextrose in case reports [<a href="#B22-medicines-12-00021" class="usa-link" aria-describedby="B22-medicines-12-00021">22</a>,<a href="#B23-medicines-12-00021" class="usa-link" aria-describedby="B23-medicines-12-00021">23</a>]. In a proposed SGLT2i DKA treatment algorithm [<a href="#B20-medicines-12-00021" class="usa-link" aria-describedby="B20-medicines-12-00021">20</a>], Chow et al. stated that a 10% dextrose infusion is preferable and necessary to prevent hypoglycemia based on the authors’ experience; however, they did not infer its role in DKA resolution. In an Australian study of 37 patients with SGLT2i diabetic ketosis with or without acidemia and 19 non-SGLT2i DKA in T1D [<a href="#B11-medicines-12-00021" class="usa-link" aria-describedby="B11-medicines-12-00021">11</a>], Umapathysivam et al. demonstrated that patients with SGLT2i DKA received a significantly lower insulin dose compared with patients with T1D DKA (44.0 [27.0–82.5] vs. 87.0 [63.0–124.0]; <em>p</em> = 0.01), corresponding with a delayed resolution of DKA compared with the T1D group (36 [24–72] vs. 18 [12–27] hours; <em>p</em> = 0.002). The concentration of dextrose and the precipitants of DKA were not specified. The authors concluded that the protracted duration of SGLT2i DKA in their cohort may be due to inadequate insulin dosing, and that an increased dextrose infusion rate (or greater dextrose concentration) would allow for increased insulin administration and ketone clearance. In our study consisting similar demographic representation of SGLT2i and non-SGLT2i DKA, 10% dextrose was the dextrose concentration of choice at initiation and was well tolerated without vascular complications, achieving a comparable DKA resolution time. In another retrospective small study comparing six SGLT2i DKA patients with 12 non-SGLT2i DKA patients [<a href="#B10-medicines-12-00021" class="usa-link" aria-describedby="B10-medicines-12-00021">10</a>], similar amounts of insulin were used in the SGLT2i DKA group compared to the non-SGLT2i DKA group (94 vs. 93 units, <em>p</em> = 0.68) along with a greater amount of 5% dextrose in the SGLT2i DKA group (9.0 vs. 2.8 L, <em>p</em> = 0.01), and a longer DKA duration in SGLT2i DKA compared to non-SGLT2i DKA (39 vs. 19 h; <em>p</em> &lt; 0.001). Thus, early utilization of 10% dextrose may be warranted for managing SGLT2i DKA to enable higher insulin doses and prompt DKA resolution, with the theoretical benefit of less hypoglycemia.</p>
<p>Another potential mechanism for the comparable resolution times of SGLT2i DKA and non-SGLT2i DKA in our study is the use of VRIII as part of our hospital’s DKA protocol, enabling intensive insulin administration. Whilst there are no head-to-head prospective study comparisons between fixed rate intravenous insulin infusion (FRIII) and VRIII in DKA, VRIII achieved early hyperglycemia correction and DKA resolution without increased hypoglycemia risk in an observational study of 97 patients with DKA [<a href="#B24-medicines-12-00021" class="usa-link" aria-describedby="B24-medicines-12-00021">24</a>]. Furthermore, VRIII was associated with a significantly lower incidence of severe hypoglycemia than FRIII (13% vs. 50%; <em>p</em> = 0.006) in a retrospective study of 67 patients with DKA (<em>n</em> = 53 VRIII and <em>n</em> = 14 FRIII) [<a href="#B25-medicines-12-00021" class="usa-link" aria-describedby="B25-medicines-12-00021">25</a>]. In our cohort, hypoglycemia occurred in 20% with VRIII, which is lower than the reported 32.5–50% in the literature with FRIII [<a href="#B25-medicines-12-00021" class="usa-link" aria-describedby="B25-medicines-12-00021">25</a>,<a href="#B26-medicines-12-00021" class="usa-link" aria-describedby="B26-medicines-12-00021">26</a>]. These studies imply that VRIII enables intensive insulin management in DKA with less hypoglycemia than FRIII. Furthermore, VRIII may be particularly beneficial due to the potential rise in glucose levels with 10% dextrose infusions. Hence, treatment of SGLT2i DKA with FRIII may not allow swift escalation of insulin therapy to meet the higher insulin requirement in SGLT2i DKA, and thus potentially prolong DKA duration.</p>
<p>The strengths of our study include detailed characterization of the management, including specification of dextrose and insulin use, which have been seldom reported in the literature limiting conclusions about the optimal management of SGLT2i DKA. Our study demonstrated for the first time that the greater prevalence of intercurrent illnesses is a potential explanation for the clinical cohort differences in higher insulin requirement and longer ICU LOS in SGLT2i DKA compared to non-SGLT2i DKA. Furthermore, in comparison with the existing literature, we demonstrated that the greater insulin requirement in SGLT2i DKA may be met with 10% dextrose and VRIII to achieve a comparable time to DKA resolution without increased adverse events. Additionally, our findings extend the work of Umapathysivam and colleagues [<a href="#B11-medicines-12-00021" class="usa-link" aria-describedby="B11-medicines-12-00021">11</a>], emphasizing the importance of intensive management of SGLT2i DKA with greater IV dextrose use with 10% dextrose as the initial dextrose concentration of choice.</p>
<p>Our study has several limitations. In our study, ketosis was defined as BOHB ketones &gt; 0.6 mmol/L corresponding with above the upper limit of normal, which is a lower cut-off than other definitions (e.g., &gt;3.0 mmol/L) [<a href="#B27-medicines-12-00021" class="usa-link" aria-describedby="B27-medicines-12-00021">27</a>,<a href="#B28-medicines-12-00021" class="usa-link" aria-describedby="B28-medicines-12-00021">28</a>]. However, reports in the literature demonstrate that people taking SGLT2i may become acidemic at a lower degree of ketonemia. In a case series of SGLT2i DKA, multiple cases were found to have acidemia despite relatively mild ketonemia (as low as 0.7 mmol/L) [<a href="#B29-medicines-12-00021" class="usa-link" aria-describedby="B29-medicines-12-00021">29</a>]. Hence, we utilized a lower definition of ketonemia to increase the sensitivity of capturing SGLT2i DKA and diabetic ketosis, similar to other studies [<a href="#B7-medicines-12-00021" class="usa-link" aria-describedby="B7-medicines-12-00021">7</a>]. However, this may lead to overdiagnosis and dilution of the severity comparisons of DKA. Our study included one SGLT2i DKA and four SGLT2i diabetic ketosis patients managed with subcutaneous insulin without IV insulin. However, the subset analysis of the SGLT2i cohort managed with subcutaneous vs. IV insulin demonstrated the benefits of IV insulin therapy, allowing more intensive insulin therapy to achieve comparable resolution of ketonemia. The disproportionate number of individuals in the subset analysis of four groups (non-SGLT2i DKA without intercurrent illnesses, non-SGLT2i DKA with intercurrent illnesses, SGLT2i DKA without intercurrent illnesses and SGLT2i DKA with intercurrent illnesses) is a limitation of the study. However, our study adds value to the literature, which currently lacks comprehensive evaluation in comparison with intercurrent illnesses, providing unique clinical insights for future study designs. The duration of ICU LOS may be confounded by non-medical confounders, such as lack of bed availability in the general wards leading to increased ICU LOS. However, all SGLT2i and non-SGLT2i group patients were exposed to this environmental confounder in a similar time frame, reducing its heterogeneity. The overall hospital LOS was not evaluated in order to mitigate the effect of non-acute medical factors such as discharge planning, as the rehabilitation waitlist was extended beyond the typical duration during the coronavirus disease pandemic. The study is from a single center, which may limit generalizability. The non-SGLT2i comparator arm was selected based on the time relative to the SGLT2i group rather than by the matching of baseline characteristics or disease severity. However, this temporal proximity matching reflects real-world clinical practice using the same protocols while minimizing variability between care providers.</p>
<p>In conclusion, the greater insulin requirement and ICU LOS in SGLT2i DKA compared to non-SGLT2i DKA may be explained by the greater prevalence of precipitating intercurrent illnesses in SGLT2i DKA and by the greater insulin resistance in T2D, which constituted the majority of cases of SGLT2i DKA. The differences observed between these cohorts reflect underlying demographic distinctions, emphasizing that the patients affected by SGLT2i DKA (predominantly those with T2D) and non-SGLT2i DKA (predominantly those with T1D) represent fundamentally different clinical entities, rather than being solely attributable to the use of SGLT2i medication. High suspicion and investigations for intercurrent illness are warranted in patients presenting with SGLT2i DKA, which typically represent comorbid individuals. Our findings in comparison to the literature imply that in SGLT2i DKA, the classically prolonged requirement for IV insulin infusion may be reduced to a duration similar to non-SGLT2i DKA through intensive management using 10% dextrose and VRIII. This management is likely to have the benefits of reduced total time on IV insulin infusion without increased adverse events in SGLT2i DKA. Guidelines for SGLT2i DKA may need to consider early utilization of 10% dextrose and VRIII. Randomized controlled trials are warranted to evaluate the efficacy of different SGLT2i DKA management strategies.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Conceptualization, Y.-A.P. and C.G.; methodology, Y.-A.P., R.D.B., S.F., and C.G.; formal analysis, Y.-A.P. and A.K.L.; data curation, A.K.L. and Y.-A.P.; writing—original draft preparation, Y.-A.P. and A.K.L.; writing—review and editing, Y.-A.P., R.D.B., F.G., S.F., and C.G.; visualization, Y.-A.P.; supervision, C.G. and S.F.; project administration, Y.-A.P. and A.K.L. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Institutional Review Board Statement</h2>
<p>The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Eastern Health Office of Research and Ethics (QA22-040-88092 approved on 11 July 2022.</p></section><section id="notes3"><h2 class="pmc_sec_title">Informed Consent Statement</h2>
<p>Informed consent was not required as the study involved a retrospective review of anonymized clinical data, with no patient contact or intervention, and was approved by the institutional review board in accordance with ethical guidelines.</p></section><section id="notes4"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy and ethical restrictions.</p></section><section id="notes5"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>S.F. has received honoraria for speaker fees from AstraZeneca, Boehringer-Ingelheim, Lilly, and Novo Nordisk, and honoraria for advisor fees from Medtronic, Mylan, Pfizer, and Sanofi. There are no disclosures for Y.P., A.K.L., R.D.B., F.G. and C.G.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This research received no external funding.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn2"><p><strong>Disclaimer/Publisher’s Note:</strong> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-medicines-12-00021">
<span class="label">1.</span><cite>O’Hara D.V., Lam C.S.P., McMurray J.J.V., Yi T.W., Hocking S., Dawson J., Raichand S., Januszewski A.S., Jardine M.J. Applications of SGLT2 inhibitors beyond glycaemic control. Nat. Rev. Nephrol. 2024;20:513–529. doi: 10.1038/s41581-024-00836-y.</cite> [<a href="https://doi.org/10.1038/s41581-024-00836-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38671190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Nephrol.&amp;title=Applications%20of%20SGLT2%20inhibitors%20beyond%20glycaemic%20control&amp;author=D.V.%20O%E2%80%99Hara&amp;author=C.S.P.%20Lam&amp;author=J.J.V.%20McMurray&amp;author=T.W.%20Yi&amp;author=S.%20Hocking&amp;volume=20&amp;publication_year=2024&amp;pages=513-529&amp;pmid=38671190&amp;doi=10.1038/s41581-024-00836-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-medicines-12-00021">
<span class="label">2.</span><cite>Davies M.J., Aroda V.R., Collins B.S., Gabbay R.A., Green J., Maruthur N.M., Rosas S.E., Del Prato S., Mathieu C., Mingrone G., et al.  Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care. 2022;45:2753–2786. doi: 10.2337/dci22-0034.</cite> [<a href="https://doi.org/10.2337/dci22-0034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10008140/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36148880/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Management%20of%20Hyperglycemia%20in%20Type%202%20Diabetes,%202022.%20A%20Consensus%20Report%20by%20the%20American%20Diabetes%20Association%20(ADA)%20and%20the%20European%20Association%20for%20the%20Study%20of%20Diabetes%20(EASD)&amp;author=M.J.%20Davies&amp;author=V.R.%20Aroda&amp;author=B.S.%20Collins&amp;author=R.A.%20Gabbay&amp;author=J.%20Green&amp;volume=45&amp;publication_year=2022&amp;pages=2753-2786&amp;pmid=36148880&amp;doi=10.2337/dci22-0034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-medicines-12-00021">
<span class="label">3.</span><cite>Committee ADAPP  Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025. Diabetes Care. 2024;48((Suppl. S1)):S207–S238. doi: 10.2337/dc25-s010.</cite> [<a href="https://doi.org/10.2337/dc25-s010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11635050/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39651970/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Cardiovascular%20Disease%20and%20Risk%20Management:%20Standards%20of%20Care%20in%20Diabetes%E2%80%942025&amp;volume=48&amp;issue=(Suppl.%20S1)&amp;publication_year=2024&amp;pages=S207-S238&amp;pmid=39651970&amp;doi=10.2337/dc25-s010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-medicines-12-00021">
<span class="label">4.</span><cite>US Food and Drug Administration  FDA Revises Labels of SGLT2 Inhibitors for Diabetes to Include Warnings About Too Much Acid in the Blood and Serious Urinary Tract Infections: Federal Register.  [(accessed on 13 February 2025)];2015  Available online:  <a href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-revises-labels-sglt2-inhibitors-diabetes-include-warnings-about-too-much-acid-blood-and-serious" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.fda.gov/drugs/drug-safety-and-availability/fda-revises-labels-sglt2-inhibitors-diabetes-include-warnings-about-too-much-acid-blood-and-serious</a>.</cite>
</li>
<li id="B5-medicines-12-00021">
<span class="label">5.</span><cite>Alkabbani W., Pelletier R., Gamble J.M. Sodium/Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events. Am. J. Epidemiol. 2021;190:1572–1581. doi: 10.1093/aje/kwab052.</cite> [<a href="https://doi.org/10.1093/aje/kwab052" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33751032/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Epidemiol.&amp;title=Sodium/Glucose%20Cotransporter%202%20Inhibitors%20and%20the%20Risk%20of%20Diabetic%20Ketoacidosis:%20An%20Example%20of%20Complementary%20Evidence%20for%20Rare%20Adverse%20Events&amp;author=W.%20Alkabbani&amp;author=R.%20Pelletier&amp;author=J.M.%20Gamble&amp;volume=190&amp;publication_year=2021&amp;pages=1572-1581&amp;pmid=33751032&amp;doi=10.1093/aje/kwab052&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-medicines-12-00021">
<span class="label">6.</span><cite>Colacci M., Fralick J., Odutayo A., Fralick M. Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis. Can. J. Diabetes. 2022;46:10–15.e2. doi: 10.1016/j.jcjd.2021.04.006.</cite> [<a href="https://doi.org/10.1016/j.jcjd.2021.04.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34116926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can.%20J.%20Diabetes&amp;title=Sodium-Glucose%20Cotransporter-2%20Inhibitors%20and%20Risk%20of%20Diabetic%20Ketoacidosis%20Among%20Adults%20With%20Type%202%20Diabetes:%20A%20Systematic%20Review%20and%20Meta-Analysis&amp;author=M.%20Colacci&amp;author=J.%20Fralick&amp;author=A.%20Odutayo&amp;author=M.%20Fralick&amp;volume=46&amp;publication_year=2022&amp;pages=10-15.e2&amp;pmid=34116926&amp;doi=10.1016/j.jcjd.2021.04.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-medicines-12-00021">
<span class="label">7.</span><cite>Hamblin P.S., Wong R., Ekinci E.I., Fourlanos S., Shah S., Jones A.R., Hare M.J.L., Calder G.L., Epa D.S., George E.M., et al.  SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission. J. Clin. Endocrinol. Metab. 2019;104:3077–3087. doi: 10.1210/jc.2019-00139.</cite> [<a href="https://doi.org/10.1210/jc.2019-00139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30835263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Endocrinol.%20Metab.&amp;title=SGLT2%20Inhibitors%20Increase%20the%20Risk%20of%20Diabetic%20Ketoacidosis%20Developing%20in%20the%20Community%20and%20During%20Hospital%20Admission&amp;author=P.S.%20Hamblin&amp;author=R.%20Wong&amp;author=E.I.%20Ekinci&amp;author=S.%20Fourlanos&amp;author=S.%20Shah&amp;volume=104&amp;publication_year=2019&amp;pages=3077-3087&amp;pmid=30835263&amp;doi=10.1210/jc.2019-00139&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-medicines-12-00021">
<span class="label">8.</span><cite>Gao F.M., Ali A.S., Bellomo R., Gaca M., Lecamwasam A., Churilov L., Ekinci E.I. A Systematic Review and Meta-analysis on the Safety and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitor Use in Hospitalized Patients. Diabetes Care. 2024;47:2275–2290. doi: 10.2337/dc24-0946.</cite> [<a href="https://doi.org/10.2337/dc24-0946" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39602586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=A%20Systematic%20Review%20and%20Meta-analysis%20on%20the%20Safety%20and%20Efficacy%20of%20Sodium%E2%80%93Glucose%20Cotransporter%202%20Inhibitor%20Use%20in%20Hospitalized%20Patients&amp;author=F.M.%20Gao&amp;author=A.S.%20Ali&amp;author=R.%20Bellomo&amp;author=M.%20Gaca&amp;author=A.%20Lecamwasam&amp;volume=47&amp;publication_year=2024&amp;pages=2275-2290&amp;pmid=39602586&amp;doi=10.2337/dc24-0946&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-medicines-12-00021">
<span class="label">9.</span><cite>Rosenstock J., Ferrannini E. Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern with SGLT2 Inhibitors. Diabetes Care. 2015;38:1638–1642. doi: 10.2337/dc15-1380.</cite> [<a href="https://doi.org/10.2337/dc15-1380" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26294774/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Euglycemic%20Diabetic%20Ketoacidosis:%20A%20Predictable,%20Detectable,%20and%20Preventable%20Safety%20Concern%20with%20SGLT2%20Inhibitors&amp;author=J.%20Rosenstock&amp;author=E.%20Ferrannini&amp;volume=38&amp;publication_year=2015&amp;pages=1638-1642&amp;pmid=26294774&amp;doi=10.2337/dc15-1380&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-medicines-12-00021">
<span class="label">10.</span><cite>Papanastasiou L., Glycofridi S., Gravvanis C., Skarakis N., Papadimitriou I., Kanti G., Kapsali C., Kounadi T. Diabetic ketoacidosis in patients treated with SGLT2 inhibitors: Experience at a tertiary hospital. Hormones. 2021;20:369–376. doi: 10.1007/s42000-020-00256-0.</cite> [<a href="https://doi.org/10.1007/s42000-020-00256-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33151508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hormones&amp;title=Diabetic%20ketoacidosis%20in%20patients%20treated%20with%20SGLT2%20inhibitors:%20Experience%20at%20a%20tertiary%20hospital&amp;author=L.%20Papanastasiou&amp;author=S.%20Glycofridi&amp;author=C.%20Gravvanis&amp;author=N.%20Skarakis&amp;author=I.%20Papadimitriou&amp;volume=20&amp;publication_year=2021&amp;pages=369-376&amp;pmid=33151508&amp;doi=10.1007/s42000-020-00256-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-medicines-12-00021">
<span class="label">11.</span><cite>Umapathysivam M.M., Morgan B., Inglis J.M., Meyer E., Liew D., Thiruvenkatarajan V., Jesudason D. SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis. JAMA Netw. Open. 2024;7:e242744. doi: 10.1001/jamanetworkopen.2024.2744.</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2024.2744" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10949093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38497966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Netw.%20Open&amp;title=SGLT2%20Inhibitor-Associated%20Ketoacidosis%20vs%20Type%201%20Diabetes-Associated%20Ketoacidosis&amp;author=M.M.%20Umapathysivam&amp;author=B.%20Morgan&amp;author=J.M.%20Inglis&amp;author=E.%20Meyer&amp;author=D.%20Liew&amp;volume=7&amp;publication_year=2024&amp;pages=e242744&amp;pmid=38497966&amp;doi=10.1001/jamanetworkopen.2024.2744&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-medicines-12-00021">
<span class="label">12.</span><cite>Clark A., Mohammed A.S., Raut A., Moore S., Houlden R., Awad S. Prevalence and Clinical Characteristics of Adults Presenting With Sodium-Glucose Cotransporter-2 Inhibitor-Associated Diabetic Ketoacidosis at a Canadian Academic Tertiary Care Hospital. Can. J. Diabetes. 2021;45:214–219. doi: 10.1016/j.jcjd.2020.08.100.</cite> [<a href="https://doi.org/10.1016/j.jcjd.2020.08.100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33046401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can.%20J.%20Diabetes&amp;title=Prevalence%20and%20Clinical%20Characteristics%20of%20Adults%20Presenting%20With%20Sodium-Glucose%20Cotransporter-2%20Inhibitor-Associated%20Diabetic%20Ketoacidosis%20at%20a%20Canadian%20Academic%20Tertiary%20Care%20Hospital&amp;author=A.%20Clark&amp;author=A.S.%20Mohammed&amp;author=A.%20Raut&amp;author=S.%20Moore&amp;author=R.%20Houlden&amp;volume=45&amp;publication_year=2021&amp;pages=214-219&amp;pmid=33046401&amp;doi=10.1016/j.jcjd.2020.08.100&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-medicines-12-00021">
<span class="label">13.</span><cite>Jeon J.Y., Kim S.K., Kim K.S., Song S.O., Yun J.S., Kim B.Y., Kim C.H., Park S.O., Hong S., Seo D.H., et al.  Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors. Diabetes Metab. 2019;45:453–457. doi: 10.1016/j.diabet.2019.01.001.</cite> [<a href="https://doi.org/10.1016/j.diabet.2019.01.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30639566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Metab.&amp;title=Clinical%20characteristics%20of%20diabetic%20ketoacidosis%20in%20users%20and%20non-users%20of%20SGLT2%20inhibitors&amp;author=J.Y.%20Jeon&amp;author=S.K.%20Kim&amp;author=K.S.%20Kim&amp;author=S.O.%20Song&amp;author=J.S.%20Yun&amp;volume=45&amp;publication_year=2019&amp;pages=453-457&amp;pmid=30639566&amp;doi=10.1016/j.diabet.2019.01.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-medicines-12-00021">
<span class="label">14.</span><cite>Almazrouei R., Afandi B., AlKindi F., Govender R., Al-Shamsi S. Clinical Characteristics and Outcomes of Diabetic Ketoacidosis in Patients With Type 2 Diabetes using SGLT2 Inhibitors. Clin. Med. Insights Endocrinol. Diabetes. 2023;16:11795514231153717. doi: 10.1177/11795514231153717.</cite> [<a href="https://doi.org/10.1177/11795514231153717" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9943955/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36844982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Med.%20Insights%20Endocrinol.%20Diabetes&amp;title=Clinical%20Characteristics%20and%20Outcomes%20of%20Diabetic%20Ketoacidosis%20in%20Patients%20With%20Type%202%20Diabetes%20using%20SGLT2%20Inhibitors&amp;author=R.%20Almazrouei&amp;author=B.%20Afandi&amp;author=F.%20AlKindi&amp;author=R.%20Govender&amp;author=S.%20Al-Shamsi&amp;volume=16&amp;publication_year=2023&amp;pages=11795514231153717&amp;pmid=36844982&amp;doi=10.1177/11795514231153717&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-medicines-12-00021">
<span class="label">15.</span><cite>Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J. Clin. Investig. 2006;116:1793–1801. doi: 10.1172/JCI29069.</cite> [<a href="https://doi.org/10.1172/JCI29069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1483173/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16823477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Investig.&amp;title=Inflammation%20and%20insulin%20resistance&amp;author=S.E.%20Shoelson&amp;author=J.%20Lee&amp;author=A.B.%20Goldfine&amp;volume=116&amp;publication_year=2006&amp;pages=1793-1801&amp;pmid=16823477&amp;doi=10.1172/JCI29069&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-medicines-12-00021">
<span class="label">16.</span><cite>de Luca C., Olefsky J.M. Inflammation and insulin resistance. FEBS Lett. 2008;582:97–105. doi: 10.1016/j.febslet.2007.11.057.</cite> [<a href="https://doi.org/10.1016/j.febslet.2007.11.057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2246086/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18053812/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Lett.&amp;title=Inflammation%20and%20insulin%20resistance&amp;author=C.%20de%20Luca&amp;author=J.M.%20Olefsky&amp;volume=582&amp;publication_year=2008&amp;pages=97-105&amp;pmid=18053812&amp;doi=10.1016/j.febslet.2007.11.057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-medicines-12-00021">
<span class="label">17.</span><cite>Drobny E.C., Abramson E.C., Baumann G. Insulin receptors in acute infection: A study of factors conferring insulin resistance. J. Clin. Endocrinol. Metab. 1984;58:710–716. doi: 10.1210/jcem-58-4-710.</cite> [<a href="https://doi.org/10.1210/jcem-58-4-710" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6365946/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Endocrinol.%20Metab.&amp;title=Insulin%20receptors%20in%20acute%20infection:%20A%20study%20of%20factors%20conferring%20insulin%20resistance&amp;author=E.C.%20Drobny&amp;author=E.C.%20Abramson&amp;author=G.%20Baumann&amp;volume=58&amp;publication_year=1984&amp;pages=710-716&amp;pmid=6365946&amp;doi=10.1210/jcem-58-4-710&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-medicines-12-00021">
<span class="label">18.</span><cite>Arneth B. Insulin Resistance and Glucose Metabolism during Infection. Endocrines. 2023;4:685–695. doi: 10.3390/endocrines4040049.</cite> [<a href="https://doi.org/10.3390/endocrines4040049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocrines&amp;title=Insulin%20Resistance%20and%20Glucose%20Metabolism%20during%20Infection&amp;author=B.%20Arneth&amp;volume=4&amp;publication_year=2023&amp;pages=685-695&amp;doi=10.3390/endocrines4040049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-medicines-12-00021">
<span class="label">19.</span><cite>Trifunovic D., Stankovic S., Sobic-Saranovic D., Marinkovic J., Petrovic M., Orlic D., Beleslin B., Banovic M., Vujisic-Tesic B., Petrovic M., et al.  Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function. Cardiovasc. Diabetol. 2014;13:73. doi: 10.1186/1475-2840-13-73.</cite> [<a href="https://doi.org/10.1186/1475-2840-13-73" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4234386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24708817/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc.%20Diabetol.&amp;title=Acute%20insulin%20resistance%20in%20ST-segment%20elevation%20myocardial%20infarction%20in%20non-diabetic%20patients%20is%20associated%20with%20incomplete%20myocardial%20reperfusion%20and%20impaired%20coronary%20microcirculatory%20function&amp;author=D.%20Trifunovic&amp;author=S.%20Stankovic&amp;author=D.%20Sobic-Saranovic&amp;author=J.%20Marinkovic&amp;author=M.%20Petrovic&amp;volume=13&amp;publication_year=2014&amp;pages=73&amp;pmid=24708817&amp;doi=10.1186/1475-2840-13-73&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-medicines-12-00021">
<span class="label">20.</span><cite>Chow E., Clement S., Garg R. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors. BMJ Open Diabetes Res. Amp. Care. 2023;11:e003666. doi: 10.1136/bmjdrc-2023-003666.</cite> [<a href="https://doi.org/10.1136/bmjdrc-2023-003666" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10551972/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37797963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Open%20Diabetes%20Res.%20Amp.%20Care&amp;title=Euglycemic%20diabetic%20ketoacidosis%20in%20the%20era%20of%20SGLT-2%20inhibitors&amp;author=E.%20Chow&amp;author=S.%20Clement&amp;author=R.%20Garg&amp;volume=11&amp;publication_year=2023&amp;pages=e003666&amp;pmid=37797963&amp;doi=10.1136/bmjdrc-2023-003666&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-medicines-12-00021">
<span class="label">21.</span><cite>Saponaro C., Pattou F., Bonner C. SGLT2 inhibition and glucagon secretion in humans. Diabetes Metab. 2018;44:383–385. doi: 10.1016/j.diabet.2018.06.005.</cite> [<a href="https://doi.org/10.1016/j.diabet.2018.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30017776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Metab.&amp;title=SGLT2%20inhibition%20and%20glucagon%20secretion%20in%20humans&amp;author=C.%20Saponaro&amp;author=F.%20Pattou&amp;author=C.%20Bonner&amp;volume=44&amp;publication_year=2018&amp;pages=383-385&amp;pmid=30017776&amp;doi=10.1016/j.diabet.2018.06.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-medicines-12-00021">
<span class="label">22.</span><cite>Bader N., Mirza L. Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin. Pak. J. Med. Sci. 2016;32:786–788. doi: 10.12669/pjms.323.9201.</cite> [<a href="https://doi.org/10.12669/pjms.323.9201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4928443/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27375734/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pak.%20J.%20Med.%20Sci.&amp;title=Euglycemic%20Diabetic%20Ketoacidosis%20in%20a%2027%20year-old%20female%20patient%20with%20type-1-Diabetes%20treated%20with%20sodium-glucose%20cotransporter-2%20(SGLT2)%20inhibitor%20Canagliflozin&amp;author=N.%20Bader&amp;author=L.%20Mirza&amp;volume=32&amp;publication_year=2016&amp;pages=786-788&amp;pmid=27375734&amp;doi=10.12669/pjms.323.9201&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-medicines-12-00021">
<span class="label">23.</span><cite>Wan Azman S.S., Sukor N., Abu Shamsi M.Y., Ismail I., Kamaruddin N.A. Case Report: High-Calorie Glucose Infusion and Tight Glycemic Control in Ameliorating Refractory Acidosis of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis. Front. Endocrinol. 2022;13:867647.  doi: 10.3389/fendo.2022.867647.</cite> [<a href="https://doi.org/10.3389/fendo.2022.867647" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9197436/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35712244/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Endocrinol.&amp;title=Case%20Report:%20High-Calorie%20Glucose%20Infusion%20and%20Tight%20Glycemic%20Control%20in%20Ameliorating%20Refractory%20Acidosis%20of%20Empagliflozin-Induced%20Euglycemic%20Diabetic%20Ketoacidosis&amp;author=S.S.%20Wan%20Azman&amp;author=N.%20Sukor&amp;author=M.Y.%20Abu%20Shamsi&amp;author=I.%20Ismail&amp;author=N.A.%20Kamaruddin&amp;volume=13&amp;publication_year=2022&amp;pages=867647&amp;pmid=35712244&amp;doi=10.3389/fendo.2022.867647&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-medicines-12-00021">
<span class="label">24.</span><cite>Koneshamoorthy A., Epa D.S., O’Neal D.N., Lee M.H., Santamaria J.D., MacIsaac R.J. Outcomes associated with a variable rate insulin infusion diabetic ketoacidosis protocol. J. Diabetes Complicat. 2024;38:108702. doi: 10.1016/j.jdiacomp.2024.108702.</cite> [<a href="https://doi.org/10.1016/j.jdiacomp.2024.108702" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38387103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Diabetes%20Complicat.&amp;title=Outcomes%20associated%20with%20a%20variable%20rate%20insulin%20infusion%20diabetic%20ketoacidosis%20protocol&amp;author=A.%20Koneshamoorthy&amp;author=D.S.%20Epa&amp;author=D.N.%20O%E2%80%99Neal&amp;author=M.H.%20Lee&amp;author=J.D.%20Santamaria&amp;volume=38&amp;publication_year=2024&amp;pages=108702&amp;pmid=38387103&amp;doi=10.1016/j.jdiacomp.2024.108702&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-medicines-12-00021">
<span class="label">25.</span><cite>Bohach N., Moorman J.M., Cunningham B., Mullen C., Fowler M.A. Comparison of Variable Versus Fixed Insulin Infusion Rate on Resolution of Diabetic Ketoacidosis. Am. J. Ther. 2023;30:e179–e185. doi: 10.1097/MJT.0000000000001619.</cite> [<a href="https://doi.org/10.1097/MJT.0000000000001619" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36867515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Ther.&amp;title=Comparison%20of%20Variable%20Versus%20Fixed%20Insulin%20Infusion%20Rate%20on%20Resolution%20of%20Diabetic%20Ketoacidosis&amp;author=N.%20Bohach&amp;author=J.M.%20Moorman&amp;author=B.%20Cunningham&amp;author=C.%20Mullen&amp;author=M.A.%20Fowler&amp;volume=30&amp;publication_year=2023&amp;pages=e179-e185&amp;pmid=36867515&amp;doi=10.1097/MJT.0000000000001619&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-medicines-12-00021">
<span class="label">26.</span><cite>Lorenson J.L., Cusumano M.C., Stewart A.M., Buhnerkempe M.G., Sanghavi D. Fixed-rate insulin for adult diabetic ketoacidosis is associated with more frequent hypoglycaemia than rate-reduction method: A retrospective cohort study. Int. J. Pharm. Pract. 2019;27:380–385. doi: 10.1111/ijpp.12525.</cite> [<a href="https://doi.org/10.1111/ijpp.12525" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30847977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Pharm.%20Pract.&amp;title=Fixed-rate%20insulin%20for%20adult%20diabetic%20ketoacidosis%20is%20associated%20with%20more%20frequent%20hypoglycaemia%20than%20rate-reduction%20method:%20A%20retrospective%20cohort%20study&amp;author=J.L.%20Lorenson&amp;author=M.C.%20Cusumano&amp;author=A.M.%20Stewart&amp;author=M.G.%20Buhnerkempe&amp;author=D.%20Sanghavi&amp;volume=27&amp;publication_year=2019&amp;pages=380-385&amp;pmid=30847977&amp;doi=10.1111/ijpp.12525&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-medicines-12-00021">
<span class="label">27.</span><cite>Umpierrez G.E., Davis G.M., ElSayed N.A., Fadini G.P., Galindo R.J., Hirsch I.B., Klonoff D.C., McCoy R.G., Misra S., Gabbay R.A., et al.  Hyperglycemic Crises in Adults with Diabetes: A Consensus Report. Diabetes Care. 2024;47:1257–1275. doi: 10.2337/dci24-0032.</cite> [<a href="https://doi.org/10.2337/dci24-0032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11272983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39052901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Hyperglycemic%20Crises%20in%20Adults%20with%20Diabetes:%20A%20Consensus%20Report&amp;author=G.E.%20Umpierrez&amp;author=G.M.%20Davis&amp;author=N.A.%20ElSayed&amp;author=G.P.%20Fadini&amp;author=R.J.%20Galindo&amp;volume=47&amp;publication_year=2024&amp;pages=1257-1275&amp;pmid=39052901&amp;doi=10.2337/dci24-0032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-medicines-12-00021">
<span class="label">28.</span><cite>Dhatariya K.K., Joint British Diabetes Societies for Inpatient Care  The management of diabetic ketoacidosis in adults—An updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabet. Med. 2022;39:e14788. doi: 10.1111/dme.14788.</cite> [<a href="https://doi.org/10.1111/dme.14788" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35224769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabet.%20Med.&amp;title=The%20management%20of%20diabetic%20ketoacidosis%20in%20adults%E2%80%94An%20updated%20guideline%20from%20the%20Joint%20British%20Diabetes%20Society%20for%20Inpatient%20Care&amp;author=K.K.%20Dhatariya&amp;volume=39&amp;publication_year=2022&amp;pages=e14788&amp;pmid=35224769&amp;doi=10.1111/dme.14788&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-medicines-12-00021">
<span class="label">29.</span><cite>Wang R., Kave B., McIlroy E., Kyi M., Colman P.G., Fourlanos S. Metabolic outcomes in patients with diabetes mellitus administered SGLT2 inhibitors immediately before emergency or elective surgery: Single centre experience and recommendations. Br. J. Anaesth. 2021;127:e5–e7. doi: 10.1016/j.bja.2021.03.023.</cite> [<a href="https://doi.org/10.1016/j.bja.2021.03.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33934891/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Anaesth.&amp;title=Metabolic%20outcomes%20in%20patients%20with%20diabetes%20mellitus%20administered%20SGLT2%20inhibitors%20immediately%20before%20emergency%20or%20elective%20surgery:%20Single%20centre%20experience%20and%20recommendations&amp;author=R.%20Wang&amp;author=B.%20Kave&amp;author=E.%20McIlroy&amp;author=M.%20Kyi&amp;author=P.G.%20Colman&amp;volume=127&amp;publication_year=2021&amp;pages=e5-e7&amp;pmid=33934891&amp;doi=10.1016/j.bja.2021.03.023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy and ethical restrictions.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Medicines are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/medicines12030021"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/medicines-12-00021.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (514.0 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12371971/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12371971/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371971%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371971/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12371971/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12371971/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40843859/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12371971/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40843859/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12371971/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12371971/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="ir2a972Ono12xmMrRAufh642OxD19JTDNhWVbM51WlriQLDk3cx3ESR2t6GlDvuu">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
